Sleep-encouraging composition and food product, pharmaceutical and feed including composition
A sleep-promoting composition using specific strains of Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Weissella, and Bifidobacterium microorganisms addresses the limitations of existing pharmaceuticals by enhancing sleep duration and reducing latency in a safe and stable manner.
Patent Information
- Application Number
- JP2024145198
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-15
AI Technical Summary
Existing sleep-promoting pharmaceuticals often have side effects and are not suitable for long-term use, and there is a need for safe and stable alternatives to improve sleep quality.
A sleep-promoting composition comprising specific strains of Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Weissella, and Bifidobacterium microorganisms, which can be incorporated into foods, medicines, and feeds to enhance sleep onset and quality.
The composition effectively increases sleep duration and reduces sleep onset latency without side effects, providing a safe and stable solution for promoting physiological sleep.
Smart Images

Figure 2024161120000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a sleep-promoting composition that can promote sleep and has excellent stability and safety. The present invention also relates to foods, medicines, and feeds containing the sleep-promoting composition. . [Background technology]
[0002] Sleep is a necessary behavior for animals to survive, and is found not only in mammals but also in fish, flies, nematodes, and other animals. In all non-mammals, sleep or sleep-like states exist. These changes have disrupted daily rhythms and increased the incidence of sleep disorders such as insomnia. According to a survey by the ministry, one in five people suffer from some kind of sleep problem (Non-Patent Document 1). Sleep disorders not only reduce work productivity due to drowsiness, but also lead to mental health problems such as dementia and depression. It has become clear that sleep is closely related to lifestyle-related diseases such as obesity and diabetes. It is estimated that the economic loss due to the shortage will be approximately 3.5 trillion yen (Non-patent Document 2).
[0003] For people with sleep disorders such as insomnia, the use of pharmaceutical sleeping pills may be considered. These include barbiturates, benzodiazepines, and non-benzodiazepines. Sleeping pills are mainly used. However, barbiturates have the potential to cause dependence. The side effects are strong, and the sleep caused by benzodiazepine sleeping pills is called benzodiazepine fast wave. It is known that it does not lead to physiological, quality sleep because it induces sleep that shows abnormal frequency ranges. It is being done.
[0004] This means that it can be taken daily instead of medicine and can induce physiological sleep. The development of materials that can do this is being actively pursued, and various materials are being developed from natural ingredients and food ingredients. For example, a deep sleep disorder improving agent using the amino acid glycine (Patent Document 1) has been proposed. ) and a sleep-promoting composition using theanine (Patent Document 2). Among lactic acid bacteria that are used in food products and are highly safe for living organisms, the non-pathogenic lactic acid bacteria La Lactobacillus acidophilus, Lactobacillus helveticus, Streptococcus - Hypnotic activity of certain strains of Thermophilus (increased REM sleep and decreased non-REM sleep) Improving sleep quality) (Patent Document 3) and Lactobacillus casei as a sleep quality improver (Patent Document Reference 4) Circadian rhythm improving agent using Lactobacillus brevis (Patent Document 5)
[0005] However, there are still enough options to satisfy the diverse needs of consumers. I can't say.
[0006] Drosophila melanogaster (hereafter referred to as "Drosophila melanogaster") The fly, called Oryza sativa, is used as a model organism in many areas of biology. In 2000, the entire genome sequence was determined, and approximately 75% of the genes related to human diseases were identified. It is believed to be present in fruit flies, and in recent years has been linked to Alzheimer's, Parkinson's and metabolic syndrome. Drosophila models of diseases such as Rhesus syndrome have been developed, and the disease is actually It is used to elucidate the mechanism of disease and to screen therapeutic drugs (Non-Patent Documents 3, 4 ).
[0007] In the field of sleep research, many studies have been conducted using Drosophila. Not only do flies exhibit sleep-like behaviors similar to those in humans, but many of their characteristics and molecular basis are also well understood. It has become clear that many aspects of sleep are common to mammalian sleep (Non-Patent Documents 5 and 6). These include age-related changes in sleep patterns (Non-Patent Document 7), homeostatic mechanisms of sleep (lost sleep), and (Non-Patent Document 8), the stimulating effect of caffeine (Non-Patent Document 9), The sleep-promoting effect of lysine (Non-Patent Document 10), dopamine, serotonin, GABA, etc. The sleep-wake regulation effects of neurotransmitters and EGF (Non-Patent Documents 11, 12, 13) It has been reported that this is common between fruit flies and mammals. The pars intercerebralis of Drosophila, which is developmentally and functionally similar to the pars intercerebralis of the brain, cerebralis) plays an important role in sleep and is involved in wake-promoting neural circuits The neural circuits that promote sleep and the sleep pathway are interconnected in Drosophila, just as they are in mammals. Despite differences in the structure of the nervous system, the neural circuits related to sleep have been conserved throughout evolution. It is known that the endothelial cell membrane is preserved (Non-Patent Documents 5 and 6).
[0008] For these reasons, Drosophila is a suitable model organism for sleep research, and the sleep system is It is also thought to be useful for discovering substances related to regulation (Non-patent Documents 5 and 6). [Prior art documents] [Patent documents]
[0009] [Patent Document 1] JP 2013-121961 A [Patent Document 2] Japanese Patent Publication No. WO01 / 074352 [Patent Document 3] Patent No. 4527922 [Patent Document 4] Patent No. 6279714 [Patent Document 5] Patent No. 5943342
Non-licensed documents
[0010]
Non-patent document 1
Non-patent document 2
Non-patent document 3
Non-patent document 4
Non-patent document 5
Non-patent document 6
[0011] The present invention provides a sleep-promoting composition that can promote sleep and has excellent stability and safety. The present invention also provides a food, medicine, or the like that contains the sleep-promoting composition. The objective of the project is to provide products and feed for the [Means for solving the problem]
[0012] The present inventors have conducted extensive research to solve the above problems and have found that multiple microorganisms are involved in sleep. It was found that this promotes That is, the present invention includes the following aspects. (1) Bacteria belonging to the genus Lactobacillus, Lactococcus, or Bifidobacterium A sleep-promoting composition comprising one or more microorganisms. (2) The sleep-promoting composition according to (1), wherein the sleep-promoting composition is a sleep-inducing composition. composition. (3) The genus Lactobacillus is Lactobacillus paracasei subspecies tolerans (Lac tobacillus paracasei subsp. tolerans) species, la Lactobacillus rhamnosus species, Lactobacillus salivarius subsp. salicinius (Lactobacillus sa livarius subsp. salicinius) species. A sleep-promoting composition according to any one of (1) and (2). (4) The genus Lactococcus is Lactococcus lactis subsp. lactis (Lac lactis subsp. lactis), Lactococcus Selected from Lactococcus raffinolactis species The sleep-promoting composition according to claim 1, wherein the composition is one or more selected from the group consisting of (1) and (2). (5) The genus Bifidobacterium is Bifidobacterium faecalis obacterium faecalis, Bifidobacterium longum subsp. Bifidobacterium longum subsp. longum ) species, Bifidobacterium longum subsp. infantis (Bifidobact erium longum subsp. infantis), Bifidobacterium Bifidobacterium pseudocatenulatum ulatum species, Bifidobacterium pseudolongum subsp. globosum (Bi fidobacterium pseudolongum subsp. globos um species, Bifidobacterium thermophilum thermophilum species according to (1) or (2), Composition for promoting sleep. (6) A sleep-promoting food comprising the sleep-promoting composition according to any one of (1) to (5). Sleep-promoting medicines or sleep-promoting feed. Effect of the Invention
[0013] The present invention provides a sleep-promoting composition capable of promoting sleep, "Promoting sleep" in this context means promoting sleep onset (increasing the amount of sleep in the early part of the night) That is, in one aspect, the present invention relates to a method for improving sleep. An introduction enhancing composition is provided. [Brief description of the drawings]
[0014] [Figure 1] FIG. 1 is a graph comparing the relative values (rates of increase in sleep amount) of the median amount of sleep in each test group to the median amount of sleep in the control group, depending on the genus of microorganism. [Diagram 2] FIG. 13 shows the sleep onset latency in the groups administered with each microorganism. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0015] The sleep-promoting composition of the present invention will be described. Actococcus, Leuconostoc, Pediococcus, Weissella, Bifidobacterium Any microorganism belonging to the genus Therium that has the effect of promoting sleep induction. It can be used.
[0016] Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, The species may be any of the genus Serra and Bifidobacterium, but preferred examples include Lactobacillus acidophilus lus species, Lactobacillus amylo vorus species, Lactobacillus delbrueckii subsp. bulgaricus (Lactoba cillus delbrueckii subsp. Bulgaricus) species, Lactobacillus fermentum species , Lactobacillus gasseri species, lactobacillus Bacillus helveticus species, Lactobacillus johnsonii species , Lactobacillus mucosae species, La Lactobacillus oris species, Lactobacillus Lactobacillus parabuchneri species, lactobacillus Bacillus paracasei subspecies tolerance (Lactobacillus paracas Tolerans), Lactobacillus plantarum (Lact obacillus plantarum species, Lactobacillus reuteri obacillus reuteri species, Lactobacillus rhamnosus (Lacto bacillus rhamnosus species, Lactobacillus sakei (Lactoba cillus sakei species, Lactobacillus salivarius subsp. salicinius (L actobacillus salivarius subsp. salicinius ) species, Lactobacillus vaginalis ) species, Lactococcus lactis subsp. lactis (Lactococcus lac Lactis subsp. Lactis species, Lactococcus raffinolactis (La ctococcus raffinolactis) species, Leuconostoc citreum (Leuconostoc citreum) species, Leuconostoc mesenteroides Leuconostoc mesenteroides subspecies dextranicum bsp. dextranicum), Leuconostoc pseudomesenteroides (Leuconostoc pseudomesenteroides) species, pedioco Pediococcus acidilactici spp. , Pediococcus pentosaceus s) species, Pediococcus stilesi i) species, Weissella cibaria species, Weissella co Weissella confusa species, Weissella paramesenteroide Weissella paramesenteroides species, Bifidobacteria Bifidobacterium adolescentis ) species, Bifidobacterium faecalis ale species, Bifidobacterium longum subsp. longum (Bifidobacterium longum Bifidobacterium longum subsp. Longum) species, Bifidobacterium longum Bifidobacterium longum subspecies infantis bsp. infantis), Bifidobacterium pseudocatenulatum (Bi fidobacterium pseudocatenulatum) species, bifidobacterium Bifidobacterium pseudolongum subsp. globosum seudolongum subsp. Globosum), Bifidobacterium Thermophilum species (Bifidobacterium thermophilum) Some examples include:
[0017] These microorganisms can be used alone or in combination of two or more kinds of microorganisms. It's fine if you're there.
[0018] Microorganisms can be cultured under conditions appropriate for each microorganism. For example, milk medium or Various culture media, including media containing milk components, semi-synthetic media not containing milk components, and chemically defined synthetic media, are available. Examples of such media include reduced skim milk and MRS medium. It is possible.
[0019] The cells separated from the culture by a collection method such as centrifugation are used as is in the present invention. It can be used as an active ingredient. Live bacteria are preferred, but bacteria that have been treated in some way can also be used. Alternatively, concentrated, dried, or freeze-dried cells may be used, or cells may be dried by heating or the like. The treatment method is not particularly limited. Not only purely isolated bacteria, but also cultures, suspensions, and other substances containing bacteria, Cytoplasm or cell wall fractions obtained by treating the cells with enzymes or physical means can also be used. The form of the culture medium is synthetic medium MRS medium (DIFCO), reconstituted skim milk, etc. In addition to cultures using media generally used for culturing lactic acid bacteria, Examples of the dairy products include fermented milk, dairy products, and lactic acid bacteria beverages, but are not limited thereto. It is not.
[0020] The sleep-promoting composition of the present invention can be added to foods, medicines, feeds, etc. The sleep-promoting composition of the present invention may be used as is, but it may also be added to foods, medicines, and feeds as is. Since it can be used with other raw materials, it can be made into powder, granules, tablets, etc. according to the usual method. It can also be used in capsules, drinks, etc. It can also be used in yogurt, milk drinks, wafers, etc. It is also possible to add the compound to foods, beverages, and feeds such as horseradish permeabilize.
[0021] When the sleep-promoting composition of the present invention is incorporated into foods, medicines, feeds, etc., the mixing ratio of the microorganisms is There are no particular limitations, and the dosage may be appropriately adjusted according to ease of production and a preferred daily dosage. The dosage is determined individually, taking into consideration the symptoms and age of the recipient. Biological cultures, etc., 10-200g, 20-200g, 50-200g, 100-200g g, 150-200g, 20-150g, 50-150g, 100-150g, or 50 ~100g, or 0.1~5,000mg, 0.2~5000mg of the bacteria itself, 0.5~5,000mg, 1~5,000mg, 2~5,000mg, 5~5,000m g, 10~5,000mg, 20~5,000mg, 50~5,000mg, 100~5 ,000mg, 200~5,000mg, 500~5,000mg, 1,000~5,0 00mg, 2,000~5,000mg, 0.2~2,000mg, 0.5~2,000 mg, 1~2,000mg, 2~2,000mg, 5~2,000mg, 10~2,00 0mg, 20~2,000mg, 50~2,000mg, 100~2,000mg, 20 0~2,000mg, 500~2,000mg, 1,000~2,000mg, 0.5~ 1,000mg, 1~1,000mg, 2~1,000mg, 5~1,000mg, 10 ~1,000mg, 20~1,000mg, 50~1,000mg, 100~1,000 mg, 200~1,000mg, 500~1,000mg, 1~500mg, 2~500 mg, 5~500mg, 10~500mg, 20~500mg, 50~500mg, 10 0~500mg, 200~500mg, 2~200mg, 5~200mg, 10~200 mg, 20~200mg, 50~200mg, 100~200mg, 5~100mg, 1 0-100mg, 20-100mg, 50-100mg, 10-50mg, or 20-5 By adjusting the amount of each ingredient, you can take in 0 mg. This allows the desired effects to be achieved.
[0022] (Method for evaluating the sleep-promoting effect of a sleep-promoting composition) The sleep-promoting effect of the sleep-promoting composition of the present invention was demonstrated using Drosophila melanogaster as described in the Examples. This can be confirmed by animal tests.
[0023] The present invention will be described in detail below with reference to examples and test examples, but these are merely illustrative. The present invention is not limited to these. EXAMPLES
[0024] (Test Example 1) Sleep-promoting effect of microorganisms Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Streptococcus Regarding various microorganisms belonging to the genera Leptococcus, Weissella, and Bifidobacterium, The sleep-promoting effect was evaluated using Drosophila. 1. Test Method (1) Donor bacteria The 21 Lactobacillus species, 2 Lactococcus species, and Leuconostoc species shown in Table 1 4 species of the genus Pediococcus, 3 species of the genus Streptococcus, 4 species of the genus Weissella One strain each of nine species of the genus Bifidobacterium was used as the donor bacteria. (2) Preparation of donor cells After culturing each donor bacterium in (1) above under the conditions shown in Table 1 (OD600 = 0.7 or higher), The cells were separated by centrifugation (7,000×g, 4°C, 20 min). After washing twice with water, the cells were suspended in 12.5% trehalose solution in an amount equal to 1 / 10 of the culture volume. This suspension was then mixed with equal amounts of 2% agar and 10% sucrose solution to form a suspension containing donor cells. The feed was prepared. (3) Test procedure Wild-type Drosophila CS 2202u The strains were cultured under a 12-h light / dark cycle at 25°C. The evaluation was performed using virgin females 5 days after emergence, reared under the following conditions: The diet consisted of the above (2) (test group) or 1% agar and 5% sucrose that did not contain lactic acid bacteria. The mice were placed in a glass tube with a diameter of 5 mm along with the diet (control group). Drosophila activity monitor to measure fruit fly behavior The behavior was measured for three days using the ing system (Trikinetics). In fruit flies, "sleep" is defined as a period of immobility (no movement) of 5 minutes or more. Therefore, we investigated the amount of sleep during the first 3 hours of the night (ZT12-15 in circadian time) on the third day of measurement. The test group and the control group were compared. Each group was evaluated using approximately 96 fruit flies. The results were evaluated by Wilcoxon rank sum test, followed by Holm's test correction. Significant differences were determined at p<0.05. It was determined that there was.
[0025] [Table 1]
[0026] 2. Test Results From Table 2, Lactobacillus acidophilus philus species, Lactobacillus amylovorus ylovorus species, Lactobacillus delbrueckii subsp. bulgaricus (Lact obacillus delbrueckii subsp. Bulgaricus) Species, Lactobacillus fermentum m) species, Lactobacillus gasseri species, Lactobacillus helveticus ) species, Lactobacillus johnsoni i) species, Lactobacillus mucosae species, Lactobacillus oris species, Lactobacillus Lactobacillus parabuchneri species, Lactobacillus paracasei subspecies tolerance casei subsp. Tolerans), Lactobacillus plantarum (L actobacillus plantarum species, Lactobacillus reuteri (L Actobacillus reuteri species, Lactobacillus rhamnosus (La ctobacillus rhamnosus species, Lactobacillus sakei (Lact obacillus sakei species, Lactobacillus salivarius subsp. salicinii Lactobacillus salivarius subsp.salicin ius species, Lactobacillus vaginalis lis species, Lactococcus lactis subsp. lactis lactis subsp. Lactis) species, Lactococcus raffinolactis (Lactococcus raffinolactis) species, Leuconostoc cit Leuconostoc citreum species, Leuconostoc mesentero Leuconostoc mesenteroides subsp. dextranicum subsp. dextranicum), Leuconostoc pseudomesentero Ides (Leuconostoc pseudomesenteroides) species, Pede Pediococcus acidilactici i) species, Pediococcus pentosa ceus species, Pediococcus stillesii esii species, Weissella cibaria species, Weissella Weissella confusa species, Weissella paramesente Weissella paramesenteroides species, Bifidobacterium Bifidobacterium adolescentis tis species, Bifidobacterium f aecale species, Bifidobacterium longum subsp. longum (Bifidoba Bifidobacterium longum subsp. Longum species, Bifidobacterium longum subsp. infantis subsp. infantis), Bifidobacterium pseudocatenulatum (Bifidobacterium pseudocatenulatum) species, bifi Bifidobacterium pseudolongum subsp. globosum m pseudolongum subsp. Globosum) species, Bifidobacterium Bifidobacterium thermophilum The amount of sleep during the early part of the night was significantly increased in the group administered the drug compared to the control group. Similarly, sleep onset latency was significantly reduced in most species tested (see also Figure 2). see).
[0027] The relative value of the median amount of sleep in each test group to the median amount of sleep in the control group was used to measure sleep increase. The results of comparing the rates of Streptococcus typhimurium by genus are shown in Figure 1. Since Thermophilus is said to have hypnotic activity, it is recommended to use the sleep-increasing agent of Streptococcus spp. When comparing the sleep increase rate of each genus with the increase rate of Bifidobacterium, the genus Bifidobacterium tended to be larger. However, the genera Lactobacillus, Leuconostoc, and Pediococcus were significantly larger. Bifidobacterium, Lactobacillus, Leuconostoc The genera Pediococcus and Lactobacillus have been shown to have particularly pronounced sleep-promoting effects.
[0028] [Table 2]
[0029] Example 1: Production of sleep-promoting agent (granules) Lactobacillus plantarum M The SN16 strain was cultured in edible synthetic medium (0.5% yeast extract, 0.1% trypticase peptidase After culturing at 38°C for 15 hours, the cells were harvested by centrifugation. The cells were freeze-dried to obtain a freeze-dried powder of the cells. g and molded into granules to obtain the sleep-promoting agent of the present invention.
[0030] (Example 2) Production of sleep-promoting agent (powder) In accordance with the provisions of the 13th revised Japanese Pharmacopoeia Commentary on Preparations General Provisions "Powder" 10 g of freeze-dried powder of MSN16 strain was mixed with 400 g of lactose (JP) and potato starch (JP). ) was added and mixed uniformly to produce the sleep-promoting agent of the present invention.
[0031] Example 3: Preparation of a sleep-promoting nutritional composition Lactobacillus plantarum M The SN16 strain was cultured in edible synthetic medium (0.5% yeast extract, 0.1% trypticase peptidase After culturing at 38°C for 15 hours, the cells were harvested by centrifugation and collected. The cells were freeze-dried. Vitamin C (40 g) or a mixture of vitamin C and citric acid (40 g) was added. g, 100 g of granulated sugar, and 60 g of an equal mixture of cornstarch and lactose. The mixture was packed into bags and used as the sleep-promoting supplement of the present invention. A nutritional composition was prepared.
[0032] Example 4: Production of a sleep-promoting beverage 1 g of the MSN16 strain obtained in Example 3 was dissolved in 699 g of deionized water, and then heated at 40° C. After heating to 100°C, the mixture was mixed with an Ultra Disperser (ULTRA-TURRAX T-25; IKA The mixture was stirred and mixed at 9,500 rpm for 20 minutes in a mixing bowl (manufactured by Japan Co., Ltd.). Add 2g of acidulant, 20g of reduced starch syrup, 2g of flavoring, and 176g of deionized water, then add 100ml The beverage was filled into glass bottles of 100 ml each, sterilized at 95° C. for 15 seconds, and then sealed. We produced a batch containing 100 ml of 1000ml ...
[0033] Example 5: Production of sleep-promoting feed Soybean meal 12kg, skimmed milk powder 14kg, soybean oil 4kg, corn oil 2kg, palm oil 23.2kg kg, corn starch 14 kg, wheat flour 9 kg, bran 2 kg, vitamin mixture 5 kg , 2.8 kg of cellulose, and 2 kg of mineral mixture were mixed and sterilized at 120°C for 4 minutes. The feed of the present invention was produced by blending 10 kg of the MSN16 strain obtained in Example 3.
[0034] (Example 6) Production of fermented milk Lactobacillus plantarum M The SN16 strain was cultured in edible synthetic medium (0.5% yeast extract, 0.1% trypticase peptidase After culturing at 37°C for 17 hours, the cells were collected by centrifugation and freeze-dried. The freeze-dried bacteria (5 g), skim milk powder (1700 g), glucose (300 g), and deionized water were mixed. 7695g was mixed and sterilized by keeping it at 95℃ for 2 hours. Then, 300 g of lactic acid bacteria starter (Lb. casei) was inoculated, stirred, and then heated to 37°C. The mixture was fermented in the incubator until the pH reached 4.0. After the pH reached 4.0, the mixture was cooled to 10°C or lower. The mixture was cooled to room temperature to produce 10 kg of the fermented milk of the present invention. [Industrial Applicability]
[0035] The present invention provides a sleep-promoting composition comprising Lactobacillus sp., Lactococcus sp., Leucobacterium sp., and Microorganisms belonging to the genera Nostoc, Pediococcus, Weissella, and Bifidobacterium The present invention provides a method for producing a food product, a composition containing the microorganism, and a food, a medicine, and a feed containing the composition. Ingestion of the composition of the present invention can promote sleep.
Claims
1. A sleep-promoting composition comprising one or more microorganisms belonging to the species Lactobacillus salivarius subsp. salicinius as an active ingredient.
2. 2. The sleep-promoting composition according to claim 1, wherein the sleep-promoting composition is a sleep-inducing composition.
3. A sleep-promoting food, medicine, or feed comprising the sleep-promoting composition according to claim 1 or 2.
Citation Information
Patent Citations
Humidity sensor material
JP1984043342A
Soil for culture of crops
JP1987079714A
Deep sleep disorder-improving agent containing glycine
JP2013121961A
Hypnotic activity of non-pathogenic lactic acid bacteria
JP4527922B2
Compositions for promoting sleep
WO2001074352A1
